Decreasing NRF2 in a hypoxic tumor reduces hypoxia-mediated deleterious metabolic activity of HIF1α (Toth and Warfel, 2017; Lee et al., 2019; Jin et al., 2020). This evidence concerns the gene HIF1A and neoplasm.